# BUPIVACAINE LIPOSOME
> **ANDA214348** · Abbreviated New Drug Application (Generic) · Sponsor: HENGRUI PHARMA · Approved 2024-07-01
## Drug
- **FDA Application Number:** ANDA214348
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPIVACAINE LIPOSOME
- **Generic name:** BUPIVACAINE
- **Active ingredients:** BUPIVACAINE
- **Dosage form:** INJECTABLE, LIPOSOMAL
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** HENGRUI PHARMA
- **Manufacturer:** Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- **First approval:** 2024-07-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214348)
---
*AI Analytics · CC0 1.0*